Today In Focus

Cancer vaccines, weight loss drugs, more

Cancer vaccines, weight loss drugs, more


IE 11 is not supported. For an optimal experience visit our site on another browser.

  • Now Playing

    2025 medical advances: Cancer vaccines, weight loss drugs, more

    02:36

  • UP NEXT

    Gal Gadot reveals blood clot during pregnancy with fourth child

    04:21

  • Norovirus outbreak surges nationwide, CDC data shows

    02:08

  • CDC releases new report on bird flu mutations in humans

    00:31

  • Soup and hot chocolate with a healthy twist perfect for cold weather

    03:33

  • How a new menopause treatment focuses on cognitive health

    04:39

  • NHL star Kevin Stevens helps others find new hope after addiction

    03:16

  • FDA approves weight loss drug Zepbound for sleep apnea

    00:22

  • New alert from CDC shows flu cases are on the rise across the US

    00:21

  • How to indulge the right way during the holiday season

    03:15

  • Self reflection tips: How to look back to move forward with intention

    04:24

  • Nurse shares health and wellness tips to start 2025 right

    04:38

  • Try these tips and strategies to help you set practical goals for 2025

    06:28

  • US obesity rates decline for the first time in more than a decade

    00:23

  • Want to strengthen your core? Try this light wrist weight workout

    03:59

  • Sleep expert shares tips to wake up refreshed during the holidays

    02:15

  • New study shows obesity rates dropping for first time in a decade

    02:09

  • Trump says he will seek to eliminate daylight saving time

    00:22

  • Tips to stay healthy during the holidays: Vaccines, cold safety, more

    04:58

  • Tips to focus on connection (not perfection) this holiday season

    05:18

From expanded eligibility for weight loss drugs to the rise of cancer vaccines, NBC medical contributor Dr. Natalie Azar joins TODAY to discuss the medical innovations set to shape 2025.



Source

Share your love
Facebook
Twitter
Newsletter

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *